Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

8 Aug 2011 11:45

RNS Number : 9283L
Oryx International Growth Fund Ld
08 August 2011
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 8 August 2011

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2011

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

This interim management statement relates to the period from 1 April 2011 to 30 June 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

Markets drifted for the majority of the period under review with the FTSE Small Cap TR Index up 0.7% and the FTSE All-Share TR Index (£) down 0.9%. It is pleasing to report that against this backdrop the net asset value rose by 8.8% to 296p per share. The increase in the portfolio was broadly based, although there was no movement in the value of the unquoted portfolio. Whilst current market conditions are difficult the manager believes there is inherent value in the portfolio which will be realised in the next quarter.

Material TransactionsSince 1 April 2011 the Company has purchased for cancellation the following shares:

15 April 2011 a total of 250,000 ordinary shares at a gross price of £2.30 per share.27 May 2011 a total of 170,000 ordinary shares at a gross price of £2.30 per share.

Material EventsThere were no material events during the quarter ended 30 June 2011.

Report and AccountsOn 30 June 2011, the Company posted its Annual Report for the year ended 31 March 2011 to Shareholders together with a circular containing the Notice convening the Company's AGM at 11am on 12 August 2011 and details of a proposed waiver of the Rule 9 provisions of the City Code on Takeovers and Mergers.

 

Financial Highlights

 

 

30 June 2011

31 March 2011

31 December 2010

30 June 2010

 

 

 

 

 

NAV

£2.96

£2.72

£2.81

£2.35

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 1.6055

 1.6029

 1.5657

 1.4961

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2011

 

% Net Assets

RPC Group Plc

7.60

CVS Group Plc

7.01

Guinness Peat Group Plc

6.72

BBA Aviation Plc

6.38

Gleeson (M.J.) Group Plc

6.11

Augean

5.34

Orthoproducts Ltd

4.68

Quarto Group Inc

4.54

GTL Resources Plc

4.19

Bavaria Industriekapital AG

4.02

Idox Plc

3.92

Sinclair Pharma Plc

3.51

Innovation Group Plc

3.39

Catalyst Media Group Plc

3.38

Redhall Group Plc

3.21

Journey Group Plc

2.99

Nastor Inv Ltd Zero Redeem Prefer Shares

2.38

Bionostics Holdings Ltd

2.19

Green Co2 Plc

2.13

Celsis AG

1.64

85.33

 

The financial information for the quarter ended 30 June 2011 contained within this Interim Management Statement has not been audited.

By order of the Board

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf ofOryx International Growth Fund Limitedas Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUUPRUPGGUR
Date   Source Headline
17th Dec 201910:44 amRNSHolding(s) in Company
17th Dec 201910:39 amRNSHolding(s) in Company
13th Dec 20197:00 amRNSHalf-year Report
9th Dec 20194:30 pmRNSHolding(s) in Company
3rd Dec 20194:33 pmRNSHolding(s) in Company
3rd Dec 201912:04 pmRNSHolding(s) in Company
25th Nov 20192:25 pmRNSNet Asset Value(s)
14th Nov 20195:24 pmRNSHolding(s) in Company
4th Nov 20191:08 pmRNSHolding(s) in Company
23rd Oct 20198:54 amRNSNet Asset Value(s)
4th Oct 20193:28 pmRNSChange of Alternative Investment Fund Manager
26th Sep 20199:38 amRNSNet Asset Value(s)
28th Aug 201911:27 amRNSResult of AGM
27th Aug 201910:13 amRNSNet Asset Value(s)
6th Aug 20192:17 pmRNSForm 8.3 - EasyHotel plc - Replacement
6th Aug 201912:07 pmRNSForm 8.3 - EasyHotel plc
5th Aug 20197:00 amRNSHolding(s) in Company
26th Jul 20195:13 pmRNSNet Asset Value(s)
26th Jul 20194:00 pmRNSNotice of AGM
5th Jul 20194:45 pmRNSAnnual Financial Report
4th Jul 20192:14 pmRNSHolding(s) in Company
2nd Jul 201911:55 amRNSNet Asset Value(s)
17th May 20195:04 pmRNSNet Asset Value(s)
24th Apr 201912:45 pmRNSNet Asset Value(s)
28th Mar 201912:37 pmRNSNet Asset Value(s)
5th Mar 20192:51 pmRNSHolding(s) in Company
26th Feb 20192:58 pmRNSHolding(s) in Company
21st Feb 20194:58 pmRNSNet Asset Value(s)
15th Feb 20193:33 pmRNSNotification of Major Holdings
23rd Jan 20193:49 pmRNSNet Asset Value(s)
21st Jan 20197:00 amRNSHoldings in Company
11th Jan 201911:54 amRNSHolding(s) in Company
3rd Jan 201910:30 amRNSNotification of Major Holdings
24th Dec 201811:11 amRNSNet Asset Value(s)
14th Dec 20187:00 amRNSHalf-year Report
12th Dec 201811:01 amRNSHolding(s) in Company
5th Dec 20182:15 pmRNSHolding(s) in Company
27th Nov 20181:50 pmRNSHoldings in Company
27th Nov 201812:55 pmRNSNet Asset Value(s)
7th Nov 201811:08 amRNSForm 8.3 - GBGI Ltd
24th Oct 20183:28 pmRNSNet Asset Value(s)
22nd Oct 20184:12 pmRNSNotification of Major Holdings
19th Oct 20184:27 pmRNSHolding(s) in Company
8th Oct 20182:38 pmRNSHolding(s) in Company
24th Sep 20185:21 pmRNSNet Asset Value(s)
11th Sep 20187:00 amRNSHolding(s) in Company
10th Sep 20185:57 pmRNSHolding(s) in Company
30th Aug 20183:09 pmRNSResult of AGM
22nd Aug 20189:46 amRNSNet Asset Value(s)
27th Jul 20185:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.